HomeCRTX • LON
CRISM' Therapeutics Corp
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(GBP) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 150.00K | -84.76% |
Net income | -6.50K | 99.86% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -146.00K | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(GBP) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.86M | -74.54% |
Total assets | 2.42M | -68.89% |
Total liabilities | 351.00K | -89.15% |
Total equity | 2.07M | — |
Shares outstanding | 32.68M | — |
Price to book | 1.58 | — |
Return on assets | -15.49% | — |
Return on capital | -18.12% | — |
Cash Flow
Net Change in Cash
Net change in cash
(GBP) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -6.50K | 99.86% |
Cash from operations | -234.00K | 78.02% |
Cash from investing | 1.17M | -93.09% |
Cash from financing | 51.00K | 100.35% |
Net change in cash | 930.50K | -29.69% |
Free cash flow | -96.69K | 84.29% |
Previous close
GBX 9.50
Day range
GBX 8.00 - GBX 9.90
Year range
GBX 5.00 - GBX 30.90
Market cap
3.24M GBP
Avg Volume
22.46K
P/E ratio
-
Dividend yield
-
Primary exchange
LON
About
Founded
2016
Website
Employees
4